20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Allergan plc Ordinary Shares (NYSE: AGN) shares are trading higher by $3.40 at $210.61 in Friday's session.
The issue has traded higher in its last five sessions and six out of its last seven. The one outlier was when it was unchanged on December 22 and 23 ($193.99). Over the seven-day span, the issue has rallied from its December 20 close ($191.33) to $212.45 earlier in today's session.
It has been a tough year for the issue (down 32 percent) from its 2015 year-end close of $312.50. The issue tumbled from the $260 area in July to $184.50 in November, when its deal to be acquired by Teva Pharmaceutics (NASDAQ: TEVA) failed to meet antitrust requirements. The month the deal was announced, Allergan made its all-time high of $340.34.
After a slightly higher open, it retreated only $0.09 to $207.51 before continuing its move higher. The current high marks it highest level since November 11, when it peaked at $216.48.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!